Sam Altman — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Formation Bio develops drugs alongside research site partners, including health systems, academic medical centers, and independent research sites, with a focus on accelerating clinical trials in dermatology, rheumatology, and cardiometabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSaaSNew York, US
Linhao Zhang(Co-Founder)Benjamine Liu(Executive Officer, Director)
BoardAlfred Lin(Director)inMichael Moritz(Director)inScott Kupor(Director)in
Co-investorsAndreessen HorowitzSection 32Sequoia CapitalThrive CapitalMantis CapitalSpark Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.